Keyword Search Year None202420232022202120202019201820172016 Relay Therapeutics Discloses Three New Programs at New Program & Platform Event June 6, 2024 Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 June 5, 2024 Relay Therapeutics to Participate in Upcoming Investor Conferences May 21, 2024 Relay Therapeutics to Host New Program and Platform Event on June 6, 2024 May 13, 2024 Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights May 2, 2024 Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024 April 25, 2024 Relay Therapeutics to Participate in Upcoming Investor Conferences April 11, 2024 Relay Therapeutics to Participate in Three Upcoming Investor Conferences February 26, 2024 Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights February 22, 2024 Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024 February 15, 2024 Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference February 1, 2024 Relay Therapeutics Announces $30 Million Private Placement Financing January 8, 2024 Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference January 2, 2024
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 June 5, 2024
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024 April 25, 2024
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights February 22, 2024
Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024 February 15, 2024
Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference February 1, 2024